Search

Your search keyword '"Lombardi D."' showing total 1,233 results

Search Constraints

Start Over You searched for: Author "Lombardi D." Remove constraint Author: "Lombardi D."
1,233 results on '"Lombardi D."'

Search Results

1. Pedagogic Strategies for Digitally Enhanced Sustainable Design

2. Structural Assessment Methods for Architectural Façade Elements in Cross-Disciplinary Collaboration Between Architects and Structural Engineers

4. Event Generators for High-Energy Physics Experiments

5. MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy

6. Nonlinear model reduction on metric spaces. Application to one-dimensional conservative PDEs in Wasserstein spaces

8. Event generators for high-energy physics experiments

10. Event generators for high-energy physics experiments

12. Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort

13. Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness

20. Current management and future challenges in salivary glands cancer

21. ROXA SMITH

23. NNLO QCD Berechnungen verbunden mit Partonenschauer für Vektorbosonpaarproduktion mittels MiNNLOPS

24. Retrieving Substitute Services Using Semantic Annotations: A Foodshop Case Study

25. Adjuvant radiotherapy and radioiodine treatment for locally advanced differentiated thyroid cancer: systematic review and meta-analysis

30. Benchmarking sustainability in cities: The role of indicators and future scenarios

32. ALLIE MCGHEE

33. ZZ production at nNNLO plus PS with MINNLOPS

34. Novel Multidisciplinary Salivary Gland Society (MSGS) Questionnaire: An International Consensus.

35. Corrigendum to 'Prognostic indicators in clinically node-negative malignant primary salivary tumours of the parotid: A multicentre experience'. [Oral Oncol. 123 (2021) 105577](S1368837521006849)(10.1016/j.oraloncology.2021.105577)

46. ROY DOWELL

50. Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial

Catalog

Books, media, physical & digital resources